{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T19:57:46Z","timestamp":1781294266627,"version":"3.54.1"},"reference-count":257,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.gene.2025.149466","type":"journal-article","created":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T23:05:05Z","timestamp":1743980705000},"page":"149466","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Cell and gene therapeutic approaches in non-alcoholic fatty liver disease"],"prefix":"10.1016","volume":"956","author":[{"given":"Mohadeseh","family":"Poudineh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Mohammadyari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negin","family":"Parsamanesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tananz","family":"Jamialahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0890-769X","authenticated-orcid":false,"given":"Prashant","family":"Kesharwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gene.2025.149466_b0110","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.3389\/fonc.2019.01182","article-title":"Oncolytic adenovirus\u2014A nova for Gene-targeted oncolytic viral therapy in HCC","volume":"9","author":"Abudoureyimu","year":"2019","journal-title":"Frontiers in Oncology."},{"issue":"1","key":"10.1016\/j.gene.2025.149466_b0920","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"New England Journal of Medicine."},{"issue":"1","key":"10.1016\/j.gene.2025.149466_b0670","doi-asserted-by":"crossref","DOI":"10.5812\/ijpr-134807","article-title":"The effect of lipopolysaccharide-stimulated adipose-derived mesenchymal stem cells on NAFLD treatment in high-fat diet-fed rats","volume":"22","author":"Afarin","year":"2023","journal-title":"Iranian Journal of Pharmaceutical Research: IJPR."},{"issue":"4","key":"10.1016\/j.gene.2025.149466_b0085","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1182\/blood-2004-04-1559","article-title":"Human mesenchymal stem cells modulate allogeneic immune cell responses","volume":"105","author":"Aggarwal","year":"2005","journal-title":"Blood."},{"issue":"6","key":"10.1016\/j.gene.2025.149466_b0070","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.jhep.2018.01.030","article-title":"Mesenchymal stromal cell therapy for liver diseases","volume":"68","author":"Alfaifi","year":"2018","journal-title":"Journal of Hepatology."},{"key":"10.1016\/j.gene.2025.149466_b0635","doi-asserted-by":"crossref","first-page":"748","DOI":"10.3389\/fphar.2017.00748","article-title":"The Human Amnion Epithelial Cell Secretome Decreases Hepatic Fibrosis in Mice with Chronic Liver Fibrosis","volume":"8","author":"Alhomrani","year":"2017","journal-title":"Front Pharmacol."},{"key":"10.1016\/j.gene.2025.149466_b0320","doi-asserted-by":"crossref","first-page":"6793","DOI":"10.1038\/35018642","article-title":"Hepatocytes from non-hepatic adult stem cells","volume":"406","author":"Alison","year":"2000","journal-title":"Nature."},{"issue":"7","key":"10.1016\/j.gene.2025.149466_b0335","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.exphem.2010.04.007","article-title":"Bone marrow stem cells and liver regeneration","volume":"38","author":"Almeida-Porada","year":"2010","journal-title":"Experimental Hematology."},{"issue":"25","key":"10.1016\/j.gene.2025.149466_b1170","first-page":"5152","article-title":"In vivo delivery of a microRNA-regulated transgene induces antigen-specific regulatory T cells and promotes immunologic tolerance","volume":"114","author":"Annoni","year":"2009","journal-title":"Blood, the Journal of the American Society of Hematology."},{"key":"10.1016\/j.gene.2025.149466_b0965","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3389\/fgene.2012.00120","article-title":"miR-34\u2013a microRNA replacement therapy is headed to the clinic","volume":"3","author":"Bader","year":"2012","journal-title":"Frontiers in Genetics."},{"issue":"5","key":"10.1016\/j.gene.2025.149466_b0870","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2174\/156652308786070961","article-title":"Physicochemical parameters of non-viral vectors that govern transfection efficiency","volume":"8","author":"Barteau","year":"2008","journal-title":"Current Gene Therapy."},{"issue":"4","key":"10.1016\/j.gene.2025.149466_b0100","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s10545-017-0053-3","article-title":"Gene therapy for monogenic liver diseases: clinical successes, current challenges and future prospects","volume":"40","author":"Baruteau","year":"2017","journal-title":"Journal of Inherited Metabolic Disease."},{"issue":"22","key":"10.1016\/j.gene.2025.149466_b0225","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1056\/NEJMoa060326","article-title":"A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis","volume":"355","author":"Belfort","year":"2006","journal-title":"New England Journal of Medicine."},{"issue":"3","key":"10.1016\/j.gene.2025.149466_b0330","doi-asserted-by":"crossref","first-page":"742","DOI":"10.3748\/wjg.v21.i3.742","article-title":"Use of mesenchymal stem cells to treat liver fibrosis: current situation and future prospects","volume":"21","author":"Berardis","year":"2015","journal-title":"World Journal of Gastroenterology: WJG."},{"issue":"7","key":"10.1016\/j.gene.2025.149466_b0120","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1136\/gutjnl-2019-318269","article-title":"Messenger RNA therapy for rare genetic metabolic diseases","volume":"68","author":"Berraondo","year":"2019","journal-title":"Gut."},{"issue":"1","key":"10.1016\/j.gene.2025.149466_b0485","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1186\/s13287-021-02663-5","article-title":"Bone marrow derived-mesenchymal stem cell improves diabetes-associated fatty liver via mitochondria transformation in mice","volume":"12","author":"Bi","year":"2021","journal-title":"Stem Cell Res Ther."},{"issue":"1","key":"10.1016\/j.gene.2025.149466_b0490","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-021-02663-5","article-title":"Bone marrow derived-mesenchymal stem cell improves diabetes-associated fatty liver via mitochondria transformation in mice","volume":"12","author":"Bi","year":"2021","journal-title":"Stem Cell Research & Therapy."},{"issue":"13","key":"10.1016\/j.gene.2025.149466_b1175","first-page":"4144","article-title":"A microRNA-regulated lentiviral vector mediates stable correction of hemophilia B mice","volume":"110","author":"Brown","year":"2007","journal-title":"Blood, the Journal of the American Society of Hematology."},{"key":"10.1016\/j.gene.2025.149466_b0600","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8468549","article-title":"Human liver stem cells suppress T-cell proliferation, NK activity, and dendritic cell differentiation","volume":"2016","author":"Bruno","year":"2016","journal-title":"Stem Cells International."},{"key":"10.1016\/j.gene.2025.149466_b0595","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6351091","article-title":"Human liver-derived stem cells improve fibrosis and inflammation associated with nonalcoholic steatohepatitis","volume":"2019","author":"Bruno","year":"2019","journal-title":"Stem Cells International."},{"issue":"2","key":"10.1016\/j.gene.2025.149466_b1260","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ymthe.2019.10.016","article-title":"HLSC-derived extracellular vesicles attenuate liver fibrosis and inflammation in a murine model of non-alcoholic steatohepatitis","volume":"28","author":"Bruno","year":"2020","journal-title":"Molecular Therapy."},{"issue":"3","key":"10.1016\/j.gene.2025.149466_b1165","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.intimp.2013.01.020","article-title":"Knockdown of hepatic aquaglyceroporin-9 alleviates high fat diet-induced non-alcoholic fatty liver disease in rats","volume":"15","author":"Cai","year":"2013","journal-title":"International Immunopharmacology."},{"issue":"2","key":"10.1016\/j.gene.2025.149466_b0465","doi-asserted-by":"crossref","first-page":"406e7","DOI":"10.1016\/j.cmet.2019.11.013","article-title":"Macrophage MerTK promotes liver fibrosis in nonalcoholic steatohepatitis","volume":"31","author":"Cai","year":"2020","journal-title":"Cell Metabolism."},{"issue":"277","key":"10.1016\/j.gene.2025.149466_b0115","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa1405","article-title":"Liver-directed lentiviral gene therapy in a dog model of hemophilia B","volume":"7","author":"Cantore","year":"2015","journal-title":"Science Translational Medicine."},{"issue":"8","key":"10.1016\/j.gene.2025.149466_b0410","doi-asserted-by":"crossref","DOI":"10.21037\/atm.2020.02.119","article-title":"Mesenchymal stem cell therapy for liver fibrosis\/cirrhosis","volume":"8","author":"Cao","year":"2020","journal-title":"Annals of Translational Medicine."},{"issue":"2","key":"10.1016\/j.gene.2025.149466_b0375","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/path.2469","article-title":"Why are MSCs therapeutic? New data: new insight","volume":"217","author":"Caplan","year":"2009","journal-title":"The Journal of Pathology: A Journal of the Pathological Society of Great Britain and Ireland."},{"key":"10.1016\/j.gene.2025.149466_b0400","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.stem.2011.06.008","article-title":"The MSC: an injury drugstore","volume":"9","author":"Caplan","year":"2011","journal-title":"Cell Stem Cell.9"},{"issue":"5","key":"10.1016\/j.gene.2025.149466_b0395","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/jcb.20886","article-title":"Mesenchymal stem cells as trophic mediators","volume":"98","author":"Caplan","year":"2006","journal-title":"Journal of Cellular Biochemistry."},{"issue":"5","key":"10.1016\/j.gene.2025.149466_b0750","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202002671RR","article-title":"Silencing of STE20\u2010type kinase MST3 in mice with antisense oligonucleotide treatment ameliorates diet\u2010induced nonalcoholic fatty liver disease","volume":"35","author":"Caputo","year":"2021","journal-title":"The FASEB Journal."},{"issue":"12","key":"10.1016\/j.gene.2025.149466_b0725","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/apt.15738","article-title":"the emerging role of genetics in precision medicine for patients with non\u2010alcoholic steatohepatitis","volume":"51","author":"Carlsson","year":"2020","journal-title":"Alimentary Pharmacology & Therapeutics."},{"issue":"4","key":"10.1016\/j.gene.2025.149466_b0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11883-015-0500-2","article-title":"FXR agonists as therapeutic agents for non-alcoholic fatty liver disease","volume":"17","author":"Carr","year":"2015","journal-title":"Current Atherosclerosis Reports."},{"issue":"22","key":"10.1016\/j.gene.2025.149466_b0850","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1038\/gt.2008.145","article-title":"Progress and prospects: zinc-finger nucleases as gene therapy agents","volume":"15","author":"Carroll","year":"2008","journal-title":"Gene Therapy."},{"issue":"39","key":"10.1016\/j.gene.2025.149466_b0460","doi-asserted-by":"crossref","first-page":"41434","DOI":"10.18632\/oncotarget.5163","article-title":"LPS-induced TNF-\u03b1 factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver disease","volume":"6","author":"Ceccarelli","year":"2015","journal-title":"Oncotarget."},{"issue":"1","key":"10.1016\/j.gene.2025.149466_b0220","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cct.2008.09.003","article-title":"Pioglitazone versus vitamin E versus placebo for the treatment of non-diabetic patients with non-alcoholic steatohepatitis: PIVENS trial design","volume":"30","author":"Chalasani","year":"2009","journal-title":"Contemporary Clinical Trials."},{"issue":"1","key":"10.1016\/j.gene.2025.149466_b0155","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology."},{"key":"10.1016\/j.gene.2025.149466_b0980","doi-asserted-by":"crossref","unstructured":"Challenges with advanced therapy medicinal products and how to meet them. Nature reviews Drug discovery. 2010;9(3):195-201.","DOI":"10.1038\/nrd3052"},{"key":"10.1016\/j.gene.2025.149466_b1210","series-title":"Stem Cells and Cancer Stem Cells, Volume 10: Therapeutic Applications in Disease and Injury","first-page":"35","article-title":"Mesenchymal stem cell survival in infarcted myocardium: adhesion and anti-death signals","author":"Chang","year":"2013"},{"issue":"1","key":"10.1016\/j.gene.2025.149466_b0480","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/0192623313508481","article-title":"Gut microbiota, low-grade inflammation, and metabolic syndrome","volume":"42","author":"Chassaing","year":"2014","journal-title":"Toxicologic Pathology."},{"issue":"13","key":"10.1016\/j.gene.2025.149466_b1135","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/sj.gt.3302494","article-title":"Primary adenovirus-specific cytotoxic T lymphocyte response occurs after viral clearance and liver enzyme elevation","volume":"12","author":"Chen","year":"2005","journal-title":"Gene Therapy."},{"issue":"21","key":"10.1016\/j.gene.2025.149466_b1120","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1016\/j.febslet.2014.09.008","article-title":"Efficient gene editing in adult mouse livers via adenoviral delivery of CRISPR\/Cas9","volume":"588","author":"Cheng","year":"2014","journal-title":"FEBS Letters."},{"issue":"6","key":"10.1016\/j.gene.2025.149466_b0540","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1007\/s13577-021-00593-1","article-title":"Human umbilical cord-derived mesenchymal stem cell-exosomal miR-627-5p ameliorates non-alcoholic fatty liver disease by repressing FTO expression","volume":"34","author":"Cheng","year":"2021","journal-title":"Human Cell."},{"issue":"12","key":"10.1016\/j.gene.2025.149466_b0775","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1080\/14728222.2021.2018418","article-title":"PNPLA3 as a therapeutic target for fatty liver disease: the evidence to date","volume":"25","author":"Cherubini","year":"2021","journal-title":"Expert Opinion on Therapeutic Targets."},{"issue":"7","key":"10.1016\/j.gene.2025.149466_b0940","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1096\/fj.201701084RR","article-title":"Therapeutic modulation of the bile acid pool by Cyp8b1 knockdown protects against nonalcoholic fatty liver disease in mice","volume":"32","author":"Chevre","year":"2018","journal-title":"The FASEB Journal."},{"key":"10.1016\/j.gene.2025.149466_b0170","unstructured":"Chitturi S, Farrell GC, editors. Etiopathogenesis of nonalcoholic steatohepatitis. Seminars in liver disease; 2001: Copyright\u00a9 2001 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New."},{"key":"10.1016\/j.gene.2025.149466_b0720","doi-asserted-by":"crossref","first-page":"2","DOI":"10.21037\/tgh.2019.09.06","article-title":"Genetic and epigenetic disease modifiers: non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD)","volume":"6","author":"Choudhary","year":"2021","journal-title":"Translational Gastroenterology and Hepatology."},{"issue":"9","key":"10.1016\/j.gene.2025.149466_b0895","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1208760","article-title":"Safety and efficacy of RNAi therapy for transthyretin amyloidosis","volume":"369","author":"Coelho","year":"2013","journal-title":"New England Journal of Medicine."},{"key":"10.1016\/j.gene.2025.149466_b0165","doi-asserted-by":"crossref","first-page":"S377","DOI":"10.1046\/j.1440-1746.17.s3.31.x","article-title":"Non\u2010alcoholic steatohepatitis: definitions and pathogenesis","volume":"17","author":"Day","year":"2002","journal-title":"Journal of Gastroenterology and Hepatology."},{"key":"10.1016\/j.gene.2025.149466_b0295","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1002\/hep.20957","article-title":"Alcohol and oxidative liver injury","volume":"43","author":"Dey","year":"2006","journal-title":"Hepatology."},{"key":"10.1016\/j.gene.2025.149466_b0005","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMra1503519","article-title":"Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis","volume":"377","author":"Diehl","year":"2017","journal-title":"N Engl J Med."},{"issue":"5","key":"10.1016\/j.gene.2025.149466_b1115","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1161\/CIRCRESAHA.115.304351","article-title":"Permanent alteration of PCSK9 with in vivo CRISPR-Cas9 genome editing","volume":"115","author":"Ding","year":"2014","journal-title":"Circulation Research."},{"issue":"6","key":"10.1016\/j.gene.2025.149466_b0805","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2174\/156652312803519788","article-title":"Gene therapy in liver diseases: state-of-the-art and future perspectives","volume":"12","author":"Domvri","year":"2012","journal-title":"Current Gene Therapy."},{"issue":"3","key":"10.1016\/j.gene.2025.149466_b0765","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jhep.2015.05.006","article-title":"Statin use and non-alcoholic steatohepatitis in at risk individuals","volume":"63","author":"Dongiovanni","year":"2015","journal-title":"Journal of Hepatology."},{"issue":"2","key":"10.1016\/j.gene.2025.149466_b1200","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/stmcls\/sxac091","article-title":"HGF secreted by menstrual blood-derived endometrial stem cells ameliorates non-alcoholic fatty liver disease through downregulation of hepatic Rnf186","volume":"41","author":"Du","year":"2023","journal-title":"Stem Cells."},{"issue":"1","key":"10.1016\/j.gene.2025.149466_b0285","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1136\/gut.23.1.8","article-title":"Inhibition of liver regeneration by chronic alcohol administration","volume":"23","author":"Duguay","year":"1982","journal-title":"Gut."},{"issue":"5","key":"10.1016\/j.gene.2025.149466_b0145","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta\u2010analysis","volume":"65","author":"Dulai","year":"2017","journal-title":"Hepatology."},{"issue":"1","key":"10.1016\/j.gene.2025.149466_b0160","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.cld.2007.02.011","article-title":"Pathogenesis of non-alcoholic steatohepatitis: human data","volume":"11","author":"Edmison","year":"2007","journal-title":"Clinics in Liver Disease."},{"key":"10.1016\/j.gene.2025.149466_b0370","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/5646384","article-title":"Human mesenchymal stromal cells from different sources diverge in their expression of cell surface proteins and display distinct differentiation patterns","author":"Elahi","year":"2016","journal-title":"Stem Cells International."},{"key":"10.1016\/j.gene.2025.149466_b0545","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114624","article-title":"Upregulation of miR-96-5p by bone marrow mesenchymal stem cells and their exosomes alleviate non-alcoholic steatohepatitis: Emphasis on caspase-2 signaling inhibition","volume":"190","author":"El-Derany","year":"2021","journal-title":"Biochemical Pharmacology."},{"issue":"3","key":"10.1016\/j.gene.2025.149466_b1270","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3390\/life12030355","article-title":"Bone Marrow Mesenchymal Stem Cells and Their Derived Extracellular Vesicles Attenuate Non-Alcoholic Steatohepatitis-Induced Cardiotoxicity via Modulating Cardiac Mechanisms","volume":"12","author":"El-Derany","year":"2022","journal-title":"Life."},{"key":"10.1016\/j.gene.2025.149466_b0045","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.756029","article-title":"Cell therapy: types, regulation, and clinical benefits","volume":"8","author":"El-Kadiry","year":"2021","journal-title":"Frontiers in Medicine."},{"issue":"5","key":"10.1016\/j.gene.2025.149466_b0650","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.jhep.2011.02.020","article-title":"Intravenous administration of multipotent stromal cells prevents the onset of non-alcoholic steatohepatitis in obese mice with metabolic syndrome","volume":"55","author":"Ezquer","year":"2011","journal-title":"Journal of Hepatology."},{"issue":"1","key":"10.1016\/j.gene.2025.149466_b0655","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-016-0469-y","article-title":"Administration of multipotent mesenchymal stromal cells restores liver regeneration and improves liver function in obese mice with hepatic steatosis after partial hepatectomy","volume":"8","author":"Ezquer","year":"2017","journal-title":"Stem Cell Research & Therapy."},{"issue":"24","key":"10.1016\/j.gene.2025.149466_b1150","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.2174\/138161211797247587","article-title":"Retroviral vector-mediated gene therapy for metabolic diseases: an update","volume":"17","author":"Ferry","year":"2011","journal-title":"Current Pharmaceutical Design."},{"issue":"6","key":"10.1016\/j.gene.2025.149466_b1235","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1089\/scd.2014.0174","article-title":"Mesenchymal stromal cells engineered to produce IGF-I by recombinant adenovirus ameliorate liver fibrosis in mice","volume":"24","author":"Fiore","year":"2015","journal-title":"Stem Cells and Development."},{"issue":"9911","key":"10.1016\/j.gene.2025.149466_b0855","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0140-6736(13)61914-5","article-title":"Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin\/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial","volume":"383","author":"Fitzgerald","year":"2014","journal-title":"The Lancet."},{"issue":"1","key":"10.1016\/j.gene.2025.149466_b0865","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJMoa1609243","article-title":"A highly durable RNAi therapeutic inhibitor of PCSK9","volume":"376","author":"Fitzgerald","year":"2017","journal-title":"New England Journal of Medicine."},{"key":"10.1016\/j.gene.2025.149466_b0175","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0168-8278(97)80496-5","article-title":"Impaired mitochondrial function in microvesicular steatosis effects of drugs, ethanol, hormones and cytokines","volume":"26","author":"Fromenty","year":"1997","journal-title":"Journal of Hepatology."},{"issue":"3","key":"10.1016\/j.gene.2025.149466_b0525","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/stem.2759","article-title":"Graft-versus-host disease amelioration by human bone marrow mesenchymal stromal\/stem cell-derived extracellular vesicles is associated with peripheral preservation of naive T cell populations","volume":"36","author":"Fujii","year":"2018","journal-title":"Stem Cells."},{"issue":"11","key":"10.1016\/j.gene.2025.149466_b0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112698","article-title":"Ethanol negatively regulates hepatic differentiation of hESC by inhibition of the MAPK\/ERK signaling pathway in vitro","volume":"9","author":"Gao","year":"2014","journal-title":"PloS One."},{"issue":"5","key":"10.1016\/j.gene.2025.149466_b1050","doi-asserted-by":"crossref","first-page":"e3015","DOI":"10.1002\/jgm.3015","article-title":"Gene therapy clinical trials worldwide to 2017: An update","volume":"20","author":"Ginn","year":"2018","journal-title":"The Journal of Gene Medicine."},{"issue":"10","key":"10.1016\/j.gene.2025.149466_b0105","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1089\/hum.2019.151","article-title":"Current status on clinical development of adeno-associated virus-mediated liver-directed gene therapy for inborn errors of metabolism","volume":"30","author":"Ginocchio","year":"2019","journal-title":"Human Gene Therapy."},{"issue":"1","key":"10.1016\/j.gene.2025.149466_b0645","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1186\/s13287-021-02476-6","article-title":"Addressing the liver progenitor cell response and hepatic oxidative stress in experimental non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis using amniotic epithelial cells","volume":"12","author":"Goonetilleke","year":"2021","journal-title":"Stem Cell Res Ther."},{"issue":"1","key":"10.1016\/j.gene.2025.149466_b1255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-021-02476-6","article-title":"Addressing the liver progenitor cell response and hepatic oxidative stress in experimental non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis using amniotic epithelial cells","volume":"12","author":"Goonetilleke","year":"2021","journal-title":"Stem Cell Research & Therapy."},{"key":"10.1016\/j.gene.2025.149466_b0565","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.scr.2018.07.015","article-title":"Establishment and characterization of an iPSC line from a 35\u00a0years old high grade patient with nonalcoholic fatty liver disease (30-40% steatosis) with homozygous wildtype PNPLA3 genotype","volume":"31","author":"Graffmann","year":"2018","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.gene.2025.149466_b0570","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.scr.2018.07.011","article-title":"Establishment and characterization of an iPSC line from a 58\u00a0years old high grade patient with nonalcoholic fatty liver disease (70% steatosis) with homozygous wildtype PNPLA3 genotype","volume":"31","author":"Graffmann","year":"2018","journal-title":"Stem Cell Res."},{"issue":"5","key":"10.1016\/j.gene.2025.149466_b0795","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/hep4.1171","article-title":"Coding variants in PNPLA3 and TM6SF2 are risk factors for hepatic steatosis and elevated serum alanine aminotransferases caused by a glucagon receptor antagonist","volume":"2","author":"Guzman","year":"2018","journal-title":"Hepatology Communications."},{"issue":"4","key":"10.1016\/j.gene.2025.149466_b0535","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/sctm.16-0226","article-title":"Extracellular vesicles from bone marrow-derived mesenchymal stem cells improve survival from lethal hepatic failure in mice","volume":"6","author":"Haga","year":"2017","journal-title":"Stem Cells Translational Medicine."},{"issue":"6","key":"10.1016\/j.gene.2025.149466_b0140","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.jhep.2017.07.027","article-title":"Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD","volume":"67","author":"Hagstr\u00f6m","year":"2017","journal-title":"Journal of Hepatology."},{"issue":"1","key":"10.1016\/j.gene.2025.149466_b0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43556-022-00088-x","article-title":"Mesenchymal stem cells-based therapy in liver diseases","volume":"3","author":"Han","year":"2022","journal-title":"Molecular Biomedicine."},{"issue":"1","key":"10.1016\/j.gene.2025.149466_b0675","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s13770-024-00675-9","article-title":"Mesenchymal Stem Cell-Derived Extracellular Vesicles Carrying Circ-Tulp4 Attenuate Diabetes Mellitus with Nonalcoholic Fatty Liver Disease by Inhibiting Cell Pyroptosis through the HNRNPC\/ABHD6 Axis","volume":"22","author":"Han","year":"2025","journal-title":"Tissue Engineering and Regenerative Medicine."},{"issue":"2","key":"10.1016\/j.gene.2025.149466_b0325","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/nprot.2012.153","article-title":"Production of hepatocyte-like cells from human pluripotent stem cells","volume":"8","author":"Hannan","year":"2013","journal-title":"Nature Protocols."},{"issue":"6894","key":"10.1016\/j.gene.2025.149466_b0840","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/418244a","article-title":"RNA interference","volume":"418","author":"Hannon","year":"2002","journal-title":"Nature."},{"issue":"11","key":"10.1016\/j.gene.2025.149466_b0210","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1038\/s41591-023-02603-1","article-title":"Resmetirom for nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled phase 3 trial","volume":"29","author":"Harrison","year":"2023","journal-title":"Nature Medicine."},{"issue":"1","key":"10.1016\/j.gene.2025.149466_b0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1478-811X-9-12","article-title":"Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC","volume":"9","author":"Hass","year":"2011","journal-title":"Cell Communication and Signaling."},{"issue":"5","key":"10.1016\/j.gene.2025.149466_b0880","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1093\/nar\/gky037","article-title":"Comparison of partially and fully chemically-modified siRNA in conjugate-mediated delivery in vivo","volume":"46","author":"Hassler","year":"2018","journal-title":"Nucleic Acids Research."},{"issue":"1","key":"10.1016\/j.gene.2025.149466_b1180","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/cei.12838","article-title":"MicroRNA-26a\u2013interleukin (IL)-6\u2013IL-17 axis regulates the development of non-alcoholic fatty liver disease in a murine model","volume":"187","author":"He","year":"2017","journal-title":"Clinical & Experimental Immunology."},{"key":"10.1016\/j.gene.2025.149466_b0090","doi-asserted-by":"crossref","DOI":"10.1177\/2040622321993442","article-title":"Mesenchymal stem cell-based treatment in autoimmune liver diseases: underlying roles, advantages and challenges","volume":"12","author":"He","year":"2021","journal-title":"Therapeutic Advances in Chronic Disease."},{"issue":"12","key":"10.1016\/j.gene.2025.149466_b0590","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1634\/stemcells.2006-0114","article-title":"Isolation and characterization of a stem cell population from adult human liver","volume":"24","author":"Herrera","year":"2006","journal-title":"Stem Cells."},{"issue":"2","key":"10.1016\/j.gene.2025.149466_b0445","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrgastro.2015.200","article-title":"Immunology in the liver\u2013from homeostasis to disease","volume":"13","author":"Heymann","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol."},{"issue":"9","key":"10.1016\/j.gene.2025.149466_b0685","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3390\/biomedicines8090350","article-title":"Mitochondrial transfer by human mesenchymal stromal cells ameliorates hepatocyte lipid load in a mouse model of NASH","volume":"8","author":"Hsu","year":"2020","journal-title":"Biomedicines."},{"issue":"6","key":"10.1016\/j.gene.2025.149466_b0715","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.jhep.2021.08.012","article-title":"Epidemiology and risk-stratification of NAFLD-associated HCC","volume":"75","author":"Ioannou","year":"2021","journal-title":"Journal of Hepatology."},{"key":"10.1016\/j.gene.2025.149466_b0660","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2021.102425","article-title":"Restorative effect of adipose tissue-derived stem cells on impaired hepatocytes through Notch signaling in non-alcoholic steatohepatitis mice","volume":"54","author":"Ishida","year":"2021","journal-title":"Stem Cell Res."},{"issue":"4","key":"10.1016\/j.gene.2025.149466_b0050","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.cell.2008.01.015","article-title":"Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming","volume":"132","author":"Jaenisch","year":"2008","journal-title":"Cell."},{"issue":"1","key":"10.1016\/j.gene.2025.149466_b0885","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-02989-4","article-title":"Selection of GalNAc-conjugated siRNAs with limited off-target-driven rat hepatotoxicity","volume":"9","author":"Janas","year":"2018","journal-title":"Nature Communications."},{"issue":"9","key":"10.1016\/j.gene.2025.149466_b1190","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.5966\/sctm.2015-0323","article-title":"Effect of function-enhanced mesenchymal stem cells infected with decorin-expressing adenovirus on hepatic fibrosis","volume":"5","author":"Jang","year":"2016","journal-title":"Stem Cells Translational Medicine."},{"issue":"18","key":"10.1016\/j.gene.2025.149466_b1045","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1242\/dev.120063","article-title":"Human pancreas development","volume":"142","author":"Jennings","year":"2015","journal-title":"Development."},{"key":"10.1016\/j.gene.2025.149466_b1100","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ebiom.2018.09.051","article-title":"Targeting hepatic miR-221\/222 for therapeutic intervention of nonalcoholic steatohepatitis in mice","volume":"37","author":"Jiang","year":"2018","journal-title":"EBioMedicine."},{"key":"10.1016\/j.gene.2025.149466_b1070","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107591","article-title":"BMP9 promotes methionine-and choline-deficient diet-induced nonalcoholic steatohepatitis in non-obese mice by enhancing NF-\u03baB dependent macrophage polarization","volume":"96","author":"Jiang","year":"2021","journal-title":"International Immunopharmacology."},{"issue":"5","key":"10.1016\/j.gene.2025.149466_b0975","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/nrg2971","article-title":"State-of-the-art gene-based therapies: the road ahead","volume":"12","author":"Kay","year":"2011","journal-title":"Nature Reviews Genetics."},{"issue":"5","key":"10.1016\/j.gene.2025.149466_b0035","doi-asserted-by":"crossref","first-page":"201","DOI":"10.5125\/jkaoms.2013.39.5.201","article-title":"A brief overview of cell therapy and its product","volume":"39","author":"Kim","year":"2013","journal-title":"Journal of the Korean Association of Oral and Maxillofacial Surgeons."},{"issue":"4","key":"10.1016\/j.gene.2025.149466_b0835","first-page":"529","article-title":"Tumor targeting by doxorubicin-RGD-4C peptide conjugate in an orthotopic mouse hepatoma model","volume":"14","author":"Kim","year":"2004","journal-title":"International Journal of Molecular Medicine."},{"issue":"13\u201314","key":"10.1016\/j.gene.2025.149466_b0475","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.clinbiochem.2015.06.023","article-title":"Gut\u2013liver axis, nutrition, and non-alcoholic fatty liver disease","volume":"48","author":"Kirpich","year":"2015","journal-title":"Clinical Biochemistry."},{"issue":"5","key":"10.1016\/j.gene.2025.149466_b0015","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.cmet.2019.10.010","article-title":"The crosstalk between hepatocytes, hepatic macrophages, and hepatic stellate cells facilitates alcoholic liver disease","volume":"30","author":"Kisseleva","year":"2019","journal-title":"Cell Metabolism."},{"key":"10.1016\/j.gene.2025.149466_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.155835","article-title":"Resmetirom, the first approved drug for the management of metabolic dysfunction-associated steatohepatitis: trials, opportunities, and challenges","volume":"154","author":"Kokkorakis","year":"2024","journal-title":"Metabolism-Clinical and Experimental."},{"issue":"7","key":"10.1016\/j.gene.2025.149466_b1000","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrg3742","article-title":"Engineering adeno-associated viruses for clinical gene therapy","volume":"15","author":"Kotterman","year":"2014","journal-title":"Nature Reviews Genetics."},{"issue":"8","key":"10.1016\/j.gene.2025.149466_b0640","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1111\/jgh.14643","article-title":"Human amnion epithelial cells and their soluble factors reduce liver fibrosis in murine non-alcoholic steatohepatitis","volume":"34","author":"Kuk","year":"2019","journal-title":"J Gastroenterol Hepatol."},{"issue":"8","key":"10.1016\/j.gene.2025.149466_b1250","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1111\/jgh.14643","article-title":"Human amnion epithelial cells and their soluble factors reduce liver fibrosis in murine non\u2010alcoholic steatohepatitis","volume":"34","author":"Kuk","year":"2019","journal-title":"Journal of Gastroenterology and Hepatology."},{"key":"10.1016\/j.gene.2025.149466_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113869","article-title":"Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis","volume":"176","author":"Kumar","year":"2021","journal-title":"Advanced Drug Delivery Reviews."},{"issue":"6","key":"10.1016\/j.gene.2025.149466_b1195","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1432-2277.2008.00652.x","article-title":"Transplantation of bone marrow\u2010derived hepatocyte stem cells transduced with adenovirus\u2010mediated IL\u201010 gene reverses liver fibrosis in rats","volume":"21","author":"Lan","year":"2008","journal-title":"Transplant International."},{"issue":"2","key":"10.1016\/j.gene.2025.149466_b0235","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1053\/j.gastro.2015.04.014","article-title":"Bariatric surgery reduces features of nonalcoholic steatohepatitis in morbidly obese patients","volume":"149","author":"Lassailly","year":"2015","journal-title":"Gastroenterology."},{"issue":"1","key":"10.1016\/j.gene.2025.149466_b0625","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13287-017-0496-3","article-title":"Human amnion epithelial cells rescue cell death via immunomodulation of microglia in a mouse model of perinatal brain injury","volume":"8","author":"Leaw","year":"2017","journal-title":"Stem Cell Res Ther."},{"issue":"12","key":"10.1016\/j.gene.2025.149466_b0405","doi-asserted-by":"crossref","first-page":"120","DOI":"10.4252\/wjsc.v4.i12.120","article-title":"Stem cell therapy independent of stemness","volume":"4","author":"Lee","year":"2012","journal-title":"World Journal of Stem Cells."},{"issue":"61\u201374","key":"10.1016\/j.gene.2025.149466_b0505","first-page":"e8","article-title":"Mesenchymal stromal cell-based therapies reduce obesity and metabolic syndromes induced by a high-fat diet","volume":"182","author":"Lee","year":"2017","journal-title":"Translational Research."},{"issue":"11","key":"10.1016\/j.gene.2025.149466_b0075","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.3390\/biomedicines9111598","article-title":"Mesenchymal stem cells influence activation of hepatic stellate cells, and constitute a promising therapy for liver fibrosis","volume":"9","author":"Lee","year":"2021","journal-title":"Biomedicines."},{"key":"10.1016\/j.gene.2025.149466_b1030","doi-asserted-by":"crossref","DOI":"10.1002\/hep.31198","article-title":"Hepatic ChREBP activation limits NAFLD development in a mouse model for Glycogen Storage Disease type Ia","volume":"72","author":"Lei","year":"2020","journal-title":"Hepatology."},{"issue":"5","key":"10.1016\/j.gene.2025.149466_b0425","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.3892\/ijmm.2016.2528","article-title":"Adipose tissue-derived stem cells promote the reversion of non-alcoholic fatty liver disease: An in vivo study","volume":"37","author":"Liao","year":"2016","journal-title":"Int J Mol Med."},{"key":"10.1016\/j.gene.2025.149466_b0680","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8628027","article-title":"Human umbilical cord-derived mesenchymal stem cell therapy ameliorates nonalcoholic fatty liver disease in obese type 2 diabetic mice","author":"Li","year":"2019","journal-title":"Stem Cells International."},{"issue":"25","key":"10.1016\/j.gene.2025.149466_b0790","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.3748\/wjg.v28.i25.2937","article-title":"Mechanism and therapeutic strategy of hepatic TM6SF2-deficient non-alcoholic fatty liver diseases via in vivo and in vitro experiments","volume":"28","author":"Li","year":"2022","journal-title":"World Journal of Gastroenterology."},{"key":"10.1016\/j.gene.2025.149466_b0730","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.molmet.2019.01.013","article-title":"Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice","volume":"22","author":"Lind\u00e9n","year":"2019","journal-title":"Molecular Metabolism."},{"issue":"7488","key":"10.1016\/j.gene.2025.149466_b1075","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nature12875","article-title":"Selection and evaluation of clinically relevant AAV variants in a xenograft liver model","volume":"506","author":"Lisowski","year":"2014","journal-title":"Nature."},{"issue":"2","key":"10.1016\/j.gene.2025.149466_b0150","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000443344","article-title":"EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease","volume":"9","author":"European Association for the Study of the Liver (EASL)","year":"2016","journal-title":"Obesity facts"},{"key":"10.1016\/j.gene.2025.149466_b0890","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.ebiom.2019.04.054","article-title":"Early blood-brain barrier dysfunction predicts neurological outcome following aneurysmal subarachnoid hemorrhage","volume":"43","author":"Lublinsky","year":"2019","journal-title":"EBioMedicine."},{"key":"10.1016\/j.gene.2025.149466_b0700","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2024.155354","article-title":"Cause and consequence of heterogeneity in human mesenchymal stem cells: Challenges in clinical application","volume":"260","author":"Lyu","year":"2024","journal-title":"Pathol Res Pract."},{"issue":"40","key":"10.1016\/j.gene.2025.149466_b1205","doi-asserted-by":"crossref","first-page":"14884","DOI":"10.3748\/wjg.v20.i40.14884","article-title":"Targeted migration of mesenchymal stem cells modified with CXCR4 to acute failing liver improves liver regeneration","volume":"20","author":"Ma","year":"2014","journal-title":"World Journal of Gastroenterology: WJG."},{"issue":"2","key":"10.1016\/j.gene.2025.149466_b1230","first-page":"260","article-title":"IL-1\u03b2 siRNA adenovirus benefits liver regeneration by improving mesenchymal stem cells survival after acute liver failure","volume":"15","author":"Ma","year":"2016","journal-title":"Annals of Hepatology."},{"issue":"3","key":"10.1016\/j.gene.2025.149466_b0735","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2024.100514","article-title":"Evaluation of antisense oligonucleotide therapy targeting Hsd17b13 in a fibrosis mice model","volume":"65","author":"Ma","year":"2024","journal-title":"Journal of Lipid Research."},{"issue":"37","key":"10.1016\/j.gene.2025.149466_b0065","doi-asserted-by":"crossref","first-page":"6276","DOI":"10.2174\/0929867326666191004161802","article-title":"Stem cell transplant for advanced stage liver disorders: current scenario and future prospects","volume":"27","author":"Mahmood","year":"2020","journal-title":"Current Medicinal Chemistry."},{"issue":"4","key":"10.1016\/j.gene.2025.149466_b0810","doi-asserted-by":"crossref","first-page":"196","DOI":"10.4103\/0970-9290.35832","article-title":"Principles of gene therapy","volume":"18","author":"Mammen","year":"2007","journal-title":"Indian Journal of Dental Research."},{"issue":"6","key":"10.1016\/j.gene.2025.149466_b0615","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038631","article-title":"Human amniotic epithelial cell transplantation induces markers of alternative macrophage activation and reduces established hepatic fibrosis","volume":"7","author":"Manuelpillai","year":"2012","journal-title":"PLoS One."},{"issue":"7","key":"10.1016\/j.gene.2025.149466_b1215","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/s41419-018-0747-y","article-title":"Anticancer chemotherapy and radiotherapy trigger both non-cell-autonomous and cell-autonomous death","volume":"9","author":"Martins","year":"2018","journal-title":"Cell Death & Disease."},{"issue":"5","key":"10.1016\/j.gene.2025.149466_b1160","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1002\/hep.24230","article-title":"Hepatocyte\u2010targeted expression by integrase\u2010defective lentiviral vectors induces antigen\u2010specific tolerance in mice with low genotoxic risk","volume":"53","author":"M\u00e1trai","year":"2011","journal-title":"Hepatology."},{"issue":"1","key":"10.1016\/j.gene.2025.149466_b0380","first-page":"1","article-title":"Human umbilical cord-derived mesenchymal stem\/stromal cells: a promising candidate for the development of advanced therapy medicinal products","volume":"12","author":"Mebarki","year":"2021","journal-title":"Stem Cell Research & Therapy."},{"issue":"9","key":"10.1016\/j.gene.2025.149466_b0020","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrendo.2017.56","article-title":"Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance","volume":"13","author":"Meex","year":"2017","journal-title":"Nature Reviews Endocrinology."},{"issue":"3","key":"10.1016\/j.gene.2025.149466_b0820","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.bbamem.2005.11.015","article-title":"Polyplex-embedding in polyelectrolyte multilayers for gene delivery","volume":"1758","author":"Meyer","year":"2006","journal-title":"Biochimica et Biophysica Acta (BBA)-Biomembranes."},{"issue":"2","key":"10.1016\/j.gene.2025.149466_b0280","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/jcp.21172","article-title":"Liver regeneration","volume":"213","author":"Michalopoulos","year":"2007","journal-title":"Journal of Cellular Physiology."},{"issue":"5","key":"10.1016\/j.gene.2025.149466_b1140","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/sj.gt.3300412","article-title":"Adenovirus-mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistence of transgene expression","volume":"4","author":"Michou","year":"1997","journal-title":"Gene Therapy."},{"issue":"5","key":"10.1016\/j.gene.2025.149466_b0995","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nrg2988","article-title":"Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges","volume":"12","author":"Mingozzi","year":"2011","journal-title":"Nature Reviews Genetics."},{"issue":"1","key":"10.1016\/j.gene.2025.149466_b0985","first-page":"23","article-title":"Immune responses to AAV vectors: overcoming barriers to successful gene therapy","volume":"122","author":"Mingozzi","year":"2013","journal-title":"Blood, the Journal of the American Society of Hematology."},{"issue":"10","key":"10.1016\/j.gene.2025.149466_b0605","doi-asserted-by":"crossref","first-page":"5807","DOI":"10.1073\/pnas.0937635100","article-title":"SHED: stem cells from human exfoliated deciduous teeth","volume":"100","author":"Miura","year":"2003","journal-title":"Proceedings of the National Academy of Sciences."},{"issue":"6","key":"10.1016\/j.gene.2025.149466_b0825","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1177\/089686080602600603","article-title":"Gene transfer using nonviral delivery systems","volume":"26","author":"Miyazaki","year":"2006","journal-title":"Peritoneal Dialysis International."},{"issue":"1","key":"10.1016\/j.gene.2025.149466_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-022-02929-6","article-title":"The role of the immune system in the pathogenesis of NAFLD and potential therapeutic impacts of mesenchymal stem cell-derived extracellular vesicles","volume":"13","author":"Moayedfard","year":"2022","journal-title":"Stem Cell Research & Therapy."},{"issue":"12","key":"10.1016\/j.gene.2025.149466_b1005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082597","article-title":"Adeno-associated viral vector serotype 5 poorly transduces liver in rat models","volume":"8","author":"Montenegro-Miranda","year":"2013","journal-title":"PLoS One."},{"issue":"6","key":"10.1016\/j.gene.2025.149466_b0255","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.tem.2022.03.005","article-title":"SGLT-2 inhibitors and GLP-1 receptor agonists in metabolic dysfunction-associated fatty liver disease","volume":"33","author":"Moon","year":"2022","journal-title":"Trends Endocrinol Metab."},{"key":"10.1016\/j.gene.2025.149466_b0260","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/4041415","article-title":"The Emerging Role of Nanomedicine in the Management of Nonalcoholic Fatty Liver Disease: A State-of-the-Art Review","author":"Moosavian","year":"2021","journal-title":"Bioinorganic Chemistry and Applications."},{"issue":"5","key":"10.1016\/j.gene.2025.149466_b0585","doi-asserted-by":"crossref","first-page":"1174e6","DOI":"10.1016\/j.jcmgh.2022.07.009","article-title":"Undifferentiated Induced Pluripotent Stem Cells as a Genetic Model for Nonalcoholic Fatty Liver Disease","volume":"14","author":"Mu\u00f1oz","year":"2022","journal-title":"Cell Mol Gastroenterol Hepatol."},{"issue":"1","key":"10.1016\/j.gene.2025.149466_b0610","doi-asserted-by":"crossref","first-page":"18778","DOI":"10.1038\/s41598-021-98254-8","article-title":"Conditioned medium from stem cells derived from human exfoliated deciduous teeth ameliorates NASH via the Gut-Liver axis","volume":"11","author":"Muto","year":"2021","journal-title":"Sci Rep."},{"issue":"1","key":"10.1016\/j.gene.2025.149466_b1285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-98254-8","article-title":"Conditioned medium from stem cells derived from human exfoliated deciduous teeth ameliorates NASH via the Gut-Liver axis","volume":"11","author":"Muto","year":"2021","journal-title":"Scientific Reports."},{"key":"10.1016\/j.gene.2025.149466_b0905","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkx818","article-title":"Impact of enhanced metabolic stability on pharmacokinetics and pharmacodynamics of GalNAc\u2013siRNA conjugates","author":"Nair","year":"2017","journal-title":"Nucleic Acids Research"},{"issue":"15","key":"10.1016\/j.gene.2025.149466_b1010","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1128\/JVI.75.15.6969-6976.2001","article-title":"Extrachromosomal recombinant adeno-associated virus vector genomes are primarily responsible for stable liver transduction in vivo","volume":"75","author":"Nakai","year":"2001","journal-title":"Journal of Virology."},{"issue":"3","key":"10.1016\/j.gene.2025.149466_b0560","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.bbrc.2015.12.007","article-title":"Hepatic maturation of human iPS cell-derived hepatocyte-like cells by ATF5, c\/EBP\u03b1, and PROX1 transduction","volume":"469","author":"Nakamori","year":"2016","journal-title":"Biochemical and Biophysical Research Communications."},{"issue":"12","key":"10.1016\/j.gene.2025.149466_b0415","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1002\/eji.201646835","article-title":"The CD45(+) fraction in murine adipose tissue derived stromal cells harbors immune-inhibitory inflammatory cells","volume":"47","author":"Nasti","year":"2017","journal-title":"Eur J Immunol."},{"issue":"1","key":"10.1016\/j.gene.2025.149466_b0450","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000518407","article-title":"The role of innate immune cells in nonalcoholic fatty liver disease","volume":"14","author":"Nati","year":"2022","journal-title":"Journal of Innate Immunity."},{"issue":"11","key":"10.1016\/j.gene.2025.149466_b0690","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.3390\/cells11111829","article-title":"Human mesenchymal stromal cells resolve lipid load in high fat diet-induced non-alcoholic steatohepatitis in mice by mitochondria donation","volume":"11","author":"Nickel","year":"2022","journal-title":"Cells."},{"issue":"1","key":"10.1016\/j.gene.2025.149466_b0435","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1080\/21623945.2022.2098583","article-title":"Adipose-derived mesenchymal stem cell-secreted extracellular vesicles alleviate non-alcoholic fatty liver disease via delivering miR-223-3p","volume":"11","author":"Niu","year":"2022","journal-title":"Adipocyte."},{"issue":"51","key":"10.1016\/j.gene.2025.149466_b0815","doi-asserted-by":"crossref","first-page":"17669","DOI":"10.1073\/pnas.0408236101","article-title":"A vesicle bioreactor as a step toward an artificial cell assembly","volume":"101","author":"Noireaux","year":"2004","journal-title":"Proceedings of the National Academy of Sciences."},{"issue":"8","key":"10.1016\/j.gene.2025.149466_b0180","article-title":"Non-Alcoholic Fatty Liver Disease and Its Association With Diabetes Mellitus","volume":"13","author":"Padda","year":"2021","journal-title":"Cureus."},{"key":"10.1016\/j.gene.2025.149466_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101122","article-title":"Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans","volume":"50","author":"Pafili","year":"2021","journal-title":"Molecular Metabolism."},{"key":"10.1016\/j.gene.2025.149466_b0385","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.biomaterials.2017.12.025","article-title":"Mesenchymal stem cell-macrophage crosstalk and bone healing","volume":"196","author":"Pajarinen","year":"2019","journal-title":"Biomaterials."},{"key":"10.1016\/j.gene.2025.149466_b1020","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/978-1-4939-9139-6_20","article-title":"AAV-mediated gene delivery to the liver: overview of current technologies and methods","author":"Palaschak","year":"2019","journal-title":"Adeno-Associated Virus Vectors."},{"key":"10.1016\/j.gene.2025.149466_b1110","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.omtm.2019.10.003","article-title":"Bi-allelic homology-directed repair with helper-dependent adenoviruses","volume":"15","author":"Palmer","year":"2019","journal-title":"Molecular Therapy-Methods & Clinical Development."},{"key":"10.1016\/j.gene.2025.149466_b1105","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.omtm.2020.01.014","article-title":"A single \u201call-in-one\u201d helper-dependent adenovirus to deliver donor DNA and CRISPR\/Cas9 for efficient homology-directed repair","volume":"17","author":"Palmer","year":"2020","journal-title":"Molecular Therapy-Methods & Clinical Development."},{"issue":"11","key":"10.1016\/j.gene.2025.149466_b0910","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/cbic.201600130","article-title":"5\u2032\u2010(E)\u2010Vinylphosphonate: A Stable Phosphate Mimic Can Improve the RNAi Activity of siRNA\u2013GalNAc Conjugates","volume":"17","author":"Parmar","year":"2016","journal-title":"ChemBioChem."},{"issue":"3","key":"10.1016\/j.gene.2025.149466_b0190","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3748\/wjg.v25.i3.308","article-title":"Elastography-based screening for esophageal varices in patients with advanced chronic liver disease","volume":"25","author":"Paternostro","year":"2019","journal-title":"World Journal of Gastroenterology."},{"issue":"1","key":"10.1016\/j.gene.2025.149466_b1080","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ymthe.2017.09.021","article-title":"Bioengineered AAV capsids with combined high human liver transduction in vivo and unique humoral seroreactivity","volume":"26","author":"Paulk","year":"2018","journal-title":"Molecular Therapy."},{"issue":"5","key":"10.1016\/j.gene.2025.149466_b0345","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/jnr.24548","article-title":"Umbilical cord blood stem cell therapy in premature brain injury: Opportunities and challenges","volume":"98","author":"Peng","year":"2020","journal-title":"Journal of Neuroscience Research."},{"key":"10.1016\/j.gene.2025.149466_b0205","article-title":"Management of non-alcoholic fatty liver disease","volume":"372","author":"Petroni","year":"2021","journal-title":"Bmj."},{"issue":"10","key":"10.1016\/j.gene.2025.149466_b0970","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/jgm.1500","article-title":"Gene therapy strategies for hemophilia: benefits versus risks","volume":"12","author":"Petrus","year":"2010","journal-title":"The Journal of Gene Medicine."},{"issue":"5","key":"10.1016\/j.gene.2025.149466_b1015","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/hae.13816","article-title":"Clinical advances in gene therapy updates on clinical trials of gene therapy in haemophilia","volume":"25","author":"Peyvandi","year":"2019","journal-title":"Haemophilia."},{"issue":"3","key":"10.1016\/j.gene.2025.149466_b0800","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/tpj.2017.45","article-title":"The PNPLA3 I148M variant is associated with transaminase elevations in type 2 diabetes patients treated with basal insulin peglispro","volume":"18","author":"Pillai","year":"2018","journal-title":"The Pharmacogenomics Journal."},{"issue":"6","key":"10.1016\/j.gene.2025.149466_b0780","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1002\/hep.28142","article-title":"The dual and opposite role of the TM6SF2\u2010rs58542926 variant in protecting against cardiovascular disease and conferring risk for nonalcoholic fatty liver: a meta\u2010analysis","volume":"62","author":"Pirola","year":"2015","journal-title":"Hepatology."},{"issue":"5","key":"10.1016\/j.gene.2025.149466_b0945","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/wrna.90","article-title":"Small RNA and transcriptional upregulation","volume":"2","author":"Portnoy","year":"2011","journal-title":"Wiley Interdisciplinary Reviews: RNA."},{"issue":"3","key":"10.1016\/j.gene.2025.149466_b0950","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/cr.2016.22","article-title":"saRNA-guided Ago2 targets the RITA complex to promoters to stimulate transcription","volume":"26","author":"Portnoy","year":"2016","journal-title":"Cell Research."},{"issue":"3","key":"10.1016\/j.gene.2025.149466_b0390","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/sj.clpt.6100313","article-title":"\u201cStemness\u201d does not explain the repair of many tissues by mesenchymal stem\/multipotent stromal cells (MSCs)","volume":"82","author":"Prockop","year":"2007","journal-title":"Clin Pharmacol Ther."},{"issue":"10","key":"10.1016\/j.gene.2025.149466_b0740","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1111\/cts.13581","article-title":"Pharmacokinetics, safety, and tolerability of BMS\u2010986263, a lipid nanoparticle containing HSP47 siRNA, in participants with hepatic impairment","volume":"16","author":"Qosa","year":"2023","journal-title":"Clinical and Translational Science."},{"issue":"5","key":"10.1016\/j.gene.2025.149466_b1035","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/hep4.1884","article-title":"Angiotensin Converting Enzyme\u20102 Therapy Improves Liver Fibrosis and Glycemic Control in Diabetic Mice With Fatty Liver","volume":"6","author":"Rajapaksha","year":"2022","journal-title":"Hepatology Communications."},{"key":"10.1016\/j.gene.2025.149466_b0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2019.154001","article-title":"Effects of newer antidiabetic drugs on nonalcoholic fatty liver and steatohepatitis: Think out of the box!","volume":"101","author":"Ranjbar","year":"2019","journal-title":"Metabolism."},{"key":"10.1016\/j.gene.2025.149466_b0925","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1056\/NEJMoa1615758","article-title":"Inclisiran in patients at high cardiovascular risk with elevated LDL cholesterol","volume":"376","author":"Ray","year":"2017","journal-title":"N Engl J Med."},{"key":"10.1016\/j.gene.2025.149466_b0455","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2741\/4892","article-title":"Current treatment paradigms and emerging therapies for NAFLD\/NASH","volume":"26","author":"Raza","year":"2021","journal-title":"Frontiers in Bioscience (landmark Edition)."},{"issue":"24","key":"10.1016\/j.gene.2025.149466_b0955","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1038\/s41388-018-0126-2","article-title":"Gene activation of CEBPA using saRNA: preclinical studies of the first in human saRNA drug candidate for liver cancer","volume":"37","author":"Reebye","year":"2018","journal-title":"Oncogene."},{"key":"10.1016\/j.gene.2025.149466_b0245","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8936865","article-title":"GLP-1 Receptor Agonist Effects on Lipid and Liver Profiles in Patients with Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis","volume":"2021","author":"Rezaei","year":"2021","journal-title":"Canadian Journal of Gastroenterology and Hepatology."},{"issue":"5","key":"10.1016\/j.gene.2025.149466_b0575","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/j.1440-1746.2008.05733.x","article-title":"Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes","volume":"24","author":"Ricchi","year":"2009","journal-title":"J Gastroenterol Hepatol."},{"issue":"10","key":"10.1016\/j.gene.2025.149466_b1085","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.3390\/ijms21103643","article-title":"High-capacity adenoviral vectors: expanding the scope of gene therapy","volume":"21","author":"Ricobaraza","year":"2020","journal-title":"International Journal of Molecular Sciences."},{"issue":"1","key":"10.1016\/j.gene.2025.149466_b0990","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/cvr\/cvv205","article-title":"Gene therapy for cardiovascular disease: advances in vector development, targeting, and delivery for clinical translation","volume":"108","author":"Rincon","year":"2015","journal-title":"Cardiovascular Research."},{"key":"10.1016\/j.gene.2025.149466_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106679","article-title":"Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)","volume":"189","author":"Rizzo","year":"2023","journal-title":"Pharmacological Research."},{"issue":"1","key":"10.1016\/j.gene.2025.149466_b0960","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00280-014-2476-y","article-title":"Development and antitumor activity of a BCL-2 targeted single-stranded DNA oligonucleotide","volume":"74","author":"Rodrigueza","year":"2014","journal-title":"Cancer Chemotherapy and Pharmacology."},{"issue":"1","key":"10.1016\/j.gene.2025.149466_b0755","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cmet.2019.12.002","article-title":"Leveraging human genetics to identify potential new treatments for fatty liver disease","volume":"31","author":"Romeo","year":"2020","journal-title":"Cell Metabolism."},{"key":"10.1016\/j.gene.2025.149466_b0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctim.2020.102322","article-title":"Effects of curcuminoids on inflammatory status in patients with non-alcoholic fatty liver disease: A randomized controlled trial","volume":"49","author":"Saberi-Karimian","year":"2020","journal-title":"Complementary Therapies in Medicine."},{"issue":"1","key":"10.1016\/j.gene.2025.149466_b0510","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.metabol.2014.10.015","article-title":"Leptin resistance and diet-induced obesity: central and peripheral actions of leptin","volume":"64","author":"S\u00e1inz","year":"2015","journal-title":"Metabolism."},{"issue":"1","key":"10.1016\/j.gene.2025.149466_b0550","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/hep.27651","article-title":"Potential of human induced pluripotent stem cells in studies of liver disease","volume":"62","author":"Sampaziotis","year":"2015","journal-title":"Hepatology."},{"issue":"1","key":"10.1016\/j.gene.2025.149466_b1125","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1040-8428(03)00172-0","article-title":"Immune responses against adenoviral vectors and their transgene products: a review of strategies for evasion","volume":"50","author":"Schagen","year":"2004","journal-title":"Critical Reviews in Oncology\/hematology."},{"issue":"8","key":"10.1016\/j.gene.2025.149466_b0305","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1097\/01.tp.0000232451.93703.ab","article-title":"Hepatocyte transplantation in an acute liver failure due to mushroom poisoning","volume":"82","author":"Schneider","year":"2006","journal-title":"Transplantation."},{"key":"10.1016\/j.gene.2025.149466_b0555","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/978-1-0716-1225-5_2","article-title":"Pluripotent Stem Cells for Cell Therapy","author":"Schroeder","year":"2021","journal-title":"In Vitro Models for Stem Cell Therapy: Methods and Protocols"},{"issue":"6","key":"10.1016\/j.gene.2025.149466_b0770","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.jhep.2015.07.036","article-title":"Treating liver fat and serum triglyceride levels in NAFLD, effects of PNPLA3 and TM6SF2 genotypes: Results from the WELCOME trial","volume":"63","author":"Scorletti","year":"2015","journal-title":"Journal of Hepatology."},{"issue":"3","key":"10.1016\/j.gene.2025.149466_b0665","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1016\/j.jacl.2022.05.058","article-title":"Mesenchymal Stromal Cell (MSC) Therapy Improve Nonalcoholic Fatty Liver Disease (NAFLD) in Long Term high Fat Diet (HFD) Induced Obesity (DIO) Mouse","volume":"16","author":"Sen","year":"2022","journal-title":"Journal of Clinical Lipidology."},{"issue":"5\u20136","key":"10.1016\/j.gene.2025.149466_b0310","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0887-2333(03)00122-X","article-title":"Functionality of cultured human hepatocytes from elective samples, cadaveric grafts and hepatectomies","volume":"17","author":"Serralta","year":"2003","journal-title":"Toxicology in Vitro."},{"issue":"10","key":"10.1016\/j.gene.2025.149466_b0315","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3727\/000000005783982495","article-title":"Influence of preservation solution on the isolation and culture of human hepatocytes from liver grafts","volume":"14","author":"Serralta","year":"2005","journal-title":"Cell Transplantation."},{"issue":"6","key":"10.1016\/j.gene.2025.149466_b0125","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41573-019-0017-4","article-title":"The current state and future directions of RNAi-based therapeutics","volume":"18","author":"Setten","year":"2019","journal-title":"Nature Reviews Drug Discovery."},{"issue":"5","key":"10.1016\/j.gene.2025.149466_b0845","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1101\/gad.880001","article-title":"RNA interference\u20142001","volume":"15","author":"Sharp","year":"2001","journal-title":"Genes & Development."},{"issue":"1","key":"10.1016\/j.gene.2025.149466_b0705","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/jgh.12656","article-title":"PNPLA 3 gene polymorphism and response to lifestyle modification in patients with nonalcoholic fatty liver disease","volume":"30","author":"Shen","year":"2015","journal-title":"Journal of Gastroenterology and Hepatology."},{"key":"10.1016\/j.gene.2025.149466_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155657","article-title":"SGLT2 inhibitor empagliflozin downregulates miRNA-34a-5p and targets GREM2 to inactivate hepatic stellate cells and ameliorate non-alcoholic fatty liver disease-associated fibrosis","volume":"146","author":"Shen","year":"2023","journal-title":"Metabolism."},{"issue":"8","key":"10.1016\/j.gene.2025.149466_b0080","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41581-018-0023-5","article-title":"Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases","volume":"14","author":"Shi","year":"2018","journal-title":"Nature Reviews Nephrology."},{"issue":"1","key":"10.1016\/j.gene.2025.149466_b0695","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-022-03201-7","article-title":"Human umbilical cord mesenchymal stromal cell-derived exosomes protect against MCD-induced NASH in a mouse model","volume":"13","author":"Shi","year":"2022","journal-title":"Stem Cell Research & Therapy."},{"key":"10.1016\/j.gene.2025.149466_b0060","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3389\/fcell.2016.00134","article-title":"Describing the stem cell potency: the various methods of functional assessment and in silico diagnostics","volume":"4","author":"Singh","year":"2016","journal-title":"Frontiers in Cell and Developmental Biology."},{"issue":"4","key":"10.1016\/j.gene.2025.149466_b0915","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1161\/CIRCULATIONAHA.118.035831","article-title":"Effects of patisiran, an RNA interference therapeutic, on cardiac parameters in patients with hereditary transthyretin-mediated amyloidosis: analysis of the APOLLO study","volume":"139","author":"Solomon","year":"2019","journal-title":"Circulation."},{"issue":"4","key":"10.1016\/j.gene.2025.149466_b0710","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3350\/cmh.2020.0136","article-title":"Precision medicine in nonalcoholic fatty liver disease: new therapeutic insights from genetics and systems biology","volume":"26","author":"Sookoian","year":"2020","journal-title":"Clinical and Molecular Hepatology."},{"issue":"3","key":"10.1016\/j.gene.2025.149466_b0875","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1089\/nat.2018.0736","article-title":"GalNAc-siRNA conjugates: leading the way for delivery of RNAi therapeutics","volume":"28","author":"Springer","year":"2018","journal-title":"Nucleic Acid Therapeutics."},{"issue":"8","key":"10.1016\/j.gene.2025.149466_b0195","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.dld.2019.01.020","article-title":"Transjugular aspiration liver biopsy performed by hepatologists trained in HVPG measurements is safe and provides important diagnostic information","volume":"51","author":"Stift","year":"2019","journal-title":"Digestive and Liver Disease."},{"issue":"12","key":"10.1016\/j.gene.2025.149466_b0200","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.dld.2020.08.028","article-title":"Comparison of the diagnostic quality of aspiration and core-biopsy needles for transjugular liver biopsy","volume":"52","author":"Stift","year":"2020","journal-title":"Digestive and Liver Disease."},{"issue":"8","key":"10.1016\/j.gene.2025.149466_b0830","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/jgm.930","article-title":"High volume hydrodynamic injection of plasmid DNA via the hepatic artery results in a high level of gene expression in rat hepatocellular carcinoma induced by diethylnitrosamine","volume":"8","author":"Tada","year":"2006","journal-title":"The Journal of Gene Medicine: A Cross\u2010disciplinary Journal for Research on the Science of Gene Transfer and Its Clinical Applications."},{"issue":"3","key":"10.1016\/j.gene.2025.149466_b0620","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3727\/096368912X661409","article-title":"Human amnion epithelial cells mediate lung repair by directly modulating macrophage recruitment and polarization","volume":"23","author":"Tan","year":"2014","journal-title":"Cell Transplant."},{"issue":"1","key":"10.1016\/j.gene.2025.149466_b1220","article-title":"Therapeutic potential of HGF\u2010expressing human umbilical cord mesenchymal stem cells in mice with acute liver failure","volume":"2016","author":"Tang","year":"2016","journal-title":"International Journal of Hepatology."},{"issue":"1","key":"10.1016\/j.gene.2025.149466_b1145","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1006\/mthe.2000.0227","article-title":"Sequestration of adenoviral vector by Kupffer cells leads to a nonlinear dose response of transduction in liver","volume":"3","author":"Tao","year":"2001","journal-title":"Molecular Therapy."},{"issue":"2","key":"10.1016\/j.gene.2025.149466_b0355","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00535-016-1258-1","article-title":"Status of and candidates for cell therapy in liver cirrhosis: overcoming the \u201cpoint of no return\u201d in advanced liver cirrhosis","volume":"52","author":"Terai","year":"2017","journal-title":"Journal of Gastroenterology."},{"issue":"6","key":"10.1016\/j.gene.2025.149466_b0760","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.jhep.2020.02.020","article-title":"Update on NAFLD genetics: from new variants to the clinic","volume":"72","author":"Tr\u00e9po","year":"2020","journal-title":"Journal of Hepatology."},{"issue":"16","key":"10.1016\/j.gene.2025.149466_b0935","doi-asserted-by":"crossref","first-page":"8489","DOI":"10.3390\/ijms22168489","article-title":"Immunonano-Lipocarrier-Mediated Liver Sinusoidal Endothelial Cell-Specific RUNX1 Inhibition Impedes Immune Cell Infiltration and Hepatic Inflammation in Murine Model of NASH","volume":"22","author":"Tripathi","year":"2021","journal-title":"International Journal of Molecular Sciences."},{"issue":"1","key":"10.1016\/j.gene.2025.149466_b0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41232-017-0045-6","article-title":"Clinical trials using mesenchymal stem cells in liver diseases and inflammatory bowel diseases","volume":"37","author":"Tsuchiya","year":"2017","journal-title":"Inflammation and Regeneration."},{"issue":"28","key":"10.1016\/j.gene.2025.149466_b1055","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abn0050","article-title":"Targeting oxidized phospholipids by AAV-based gene therapy in mice with established hepatic steatosis prevents progression to fibrosis","volume":"8","author":"Upchurch","year":"2022","journal-title":"Science Advances."},{"issue":"6","key":"10.1016\/j.gene.2025.149466_b1025","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/mt.2016.61","article-title":"Superior in vivo transduction of human hepatocytes using engineered AAV3 capsid","volume":"24","author":"Vercauteren","year":"2016","journal-title":"Molecular Therapy."},{"key":"10.1016\/j.gene.2025.149466_b0040","article-title":"American society of gene and cell therapy (ASGCT) 24th annual meeting","volume":"671\u20136","author":"Verges","year":"2021","journal-title":"Drugs of the Future."},{"issue":"2","key":"10.1016\/j.gene.2025.149466_b0185","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jhep.2017.11.013","article-title":"Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers","volume":"68","author":"Vilar-Gomez","year":"2018","journal-title":"Journal of Hepatology."},{"issue":"6","key":"10.1016\/j.gene.2025.149466_b0030","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41575-020-00408-y","article-title":"Therapeutic pipeline in nonalcoholic steatohepatitis","volume":"18","author":"Vuppalanchi","year":"2021","journal-title":"Nature Reviews Gastroenterology & Hepatology."},{"key":"10.1016\/j.gene.2025.149466_b0290","doi-asserted-by":"crossref","unstructured":"Wands J, Carter E, Bucher N, Isselbacher K. Effect of acute and chronic ethanol intoxication on hepatic regeneration. Alcohol and Aldehyde Metabolizing Systems-IV: Springer; 1980. p. 663-70.","DOI":"10.1007\/978-1-4757-1419-7_69"},{"issue":"5935","key":"10.1016\/j.gene.2025.149466_b1040","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1126\/science.1174497","article-title":"Dynamic signaling network for the specification of embryonic pancreas and liver progenitors","volume":"324","author":"Wandzioch","year":"2009","journal-title":"Science."},{"issue":"7","key":"10.1016\/j.gene.2025.149466_b1130","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1089\/hum.2015.087","article-title":"Adenovirus-mediated somatic genome editing of Pten by CRISPR\/Cas9 in mouse liver in spite of Cas9-specific immune responses","volume":"26","author":"Wang","year":"2015","journal-title":"Human Gene Therapy."},{"issue":"24","key":"10.1016\/j.gene.2025.149466_b0520","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1089\/scd.2016.0107","article-title":"Extracellular vesicles released from human umbilical cord-derived mesenchymal stromal cells prevent life-threatening acute graft-versus-host disease in a mouse model of allogeneic hematopoietic stem cell transplantation","volume":"25","author":"Wang","year":"2016","journal-title":"Stem Cells and Development."},{"key":"10.1016\/j.gene.2025.149466_b0340","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.intimp.2016.11.012","article-title":"Compact bone-derived mesenchymal stem cells attenuate nonalcoholic steatohepatitis in a mouse model by modulation of CD4 cells differentiation","volume":"42","author":"Wang","year":"2017","journal-title":"International Immunopharmacology."},{"issue":"3","key":"10.1016\/j.gene.2025.149466_b0495","first-page":"3769","article-title":"Mesenchymal stem cells reverse high\u2011fat diet\u2011induced non\u2011alcoholic fatty liver disease through suppression of CD4+ T lymphocytes in mice","volume":"17","author":"Wang","year":"2018","journal-title":"Molecular Medicine Reports."},{"key":"10.1016\/j.gene.2025.149466_b1065","doi-asserted-by":"crossref","unstructured":"Weber M, Mera P, Casas J, Salvador J, Rodr\u00edguez A, Alonso S, et al., editors. Liver CPT1A gene therapy reduces diet\u2010induced hepatic steatosis in mice and highlights potential lipid biomarkers for human NAFLD. Federation of American Societies for Experimental Biology; 2020: John Wiley & Sons, Inc.","DOI":"10.1096\/fj.202000678R"},{"issue":"3","key":"10.1016\/j.gene.2025.149466_b0470","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2019.05.002","article-title":"Inhibiting interleukin 11 signaling reduces hepatocyte death and liver fibrosis, inflammation, and steatosis in mouse models of nonalcoholic steatohepatitis","volume":"157","author":"Widjaja","year":"2019","journal-title":"Gastroenterology."},{"issue":"9","key":"10.1016\/j.gene.2025.149466_b0860","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nrg3978","article-title":"Knocking down disease: a progress report on siRNA therapeutics","volume":"16","author":"Wittrup","year":"2015","journal-title":"Nature Reviews Genetics."},{"issue":"3","key":"10.1016\/j.gene.2025.149466_b1090","doi-asserted-by":"crossref","first-page":"E436","DOI":"10.1152\/ajpendo.00454.2018","article-title":"Mouse trefoil factor 3 ameliorated high-fat-diet-induced hepatic steatosis via increasing peroxisome proliferator-activated receptor-\u03b1-mediated fatty acid oxidation","volume":"317","author":"Wu","year":"2019","journal-title":"American Journal of Physiology-Endocrinology and Metabolism."},{"key":"10.1016\/j.gene.2025.149466_b0745","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.85131","article-title":"Amelioration of non-alcoholic fatty liver disease by targeting adhesion G protein-coupled receptor F1 (Adgrf1)","volume":"12","author":"Wu","year":"2023","journal-title":"Elife."},{"issue":"7","key":"10.1016\/j.gene.2025.149466_b1185","doi-asserted-by":"crossref","first-page":"5864","DOI":"10.1002\/jcb.26776","article-title":"MicroRNA\u2010190b regulates lipid metabolism and insulin sensitivity by targeting IGF\u20101 and ADAMTS9 in non\u2010alcoholic fatty liver disease","volume":"119","author":"Xu","year":"2018","journal-title":"Journal of Cellular Biochemistry."},{"key":"10.1016\/j.gene.2025.149466_b1275","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2020.101382","article-title":"Liraglutide in combination with human umbilical cord mesenchymal stem cell could improve liver lesions by modulating TLR4\/NF-kB inflammatory pathway and oxidative stress in T2DM\/NAFLD rats","volume":"66","author":"Xu","year":"2020","journal-title":"Tissue and Cell."},{"issue":"1","key":"10.1016\/j.gene.2025.149466_b0785","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41392-022-01119-3","article-title":"Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver\/steatohepatitis (NAFL\/NASH)","volume":"7","author":"Xu","year":"2022","journal-title":"Signal Transduction and Targeted Therapy."},{"key":"10.1016\/j.gene.2025.149466_b0515","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cca.2012.12.007","article-title":"Role of leptin and adiponectin in insulin resistance","volume":"417","author":"Yadav","year":"2013","journal-title":"Clinica Chimica Acta."},{"issue":"8","key":"10.1016\/j.gene.2025.149466_b0430","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/jgh.14647","article-title":"Adipose tissue-derived stem cells prevent fibrosis in murine steatohepatitis by suppressing IL-17-mediated inflammation","volume":"34","author":"Yamato","year":"2019","journal-title":"J Gastroenterol Hepatol."},{"issue":"8","key":"10.1016\/j.gene.2025.149466_b1245","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/jgh.14647","article-title":"Adipose tissue\u2010derived stem cells prevent fibrosis in murine steatohepatitis by suppressing IL\u201017\u2010mediated inflammation","volume":"34","author":"Yamato","year":"2019","journal-title":"Journal of Gastroenterology and Hepatology."},{"issue":"21","key":"10.1016\/j.gene.2025.149466_b0500","doi-asserted-by":"crossref","first-page":"21660","DOI":"10.18632\/aging.103962","article-title":"Human mesenchymal stem cells treatment improved hepatic lesions and reversed gut microbiome disorder in non-alcoholic steatohepatitis","volume":"12","author":"Yang","year":"2020","journal-title":"Aging (albany NY)."},{"issue":"21","key":"10.1016\/j.gene.2025.149466_b1265","doi-asserted-by":"crossref","first-page":"21660","DOI":"10.18632\/aging.103962","article-title":"Human mesenchymal stem cells treatment improved hepatic lesions and reversed gut microbiome disorder in non-alcoholic steatohepatitis","volume":"12","author":"Yang","year":"2020","journal-title":"Aging (albany NY)."},{"key":"10.1016\/j.gene.2025.149466_b1280","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.bbrc.2021.01.098","article-title":"Mesenchymal stem cell-conditioned medium improved mitochondrial function and alleviated inflammation and apoptosis in non-alcoholic fatty liver disease by regulating SIRT1","volume":"546","author":"Yang","year":"2021","journal-title":"Biochemical and Biophysical Research Communications."},{"key":"10.1016\/j.gene.2025.149466_b1240","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.reth.2021.11.005","article-title":"Characterization of adipose tissue-derived stromal cells of mice with nonalcoholic fatty liver disease and their use for liver repair","volume":"18","author":"Yano","year":"2021","journal-title":"Regenerative Therapy."},{"issue":"3","key":"10.1016\/j.gene.2025.149466_b0930","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.ymthe.2021.11.007","article-title":"An RNAi therapeutic targeting hepatic DGAT2 in a genetically obese mouse model of nonalcoholic steatohepatitis","volume":"30","author":"Yenilmez","year":"2022","journal-title":"Molecular Therapy."},{"issue":"9","key":"10.1016\/j.gene.2025.149466_b1155","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/bies.201300049","article-title":"Are human endogenous retroviruses pathogenic? An approach to testing the hypothesis","volume":"35","author":"Young","year":"2013","journal-title":"Bioessays."},{"issue":"1","key":"10.1016\/j.gene.2025.149466_b0135","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease\u2014meta\u2010analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology."},{"issue":"1","key":"10.1016\/j.gene.2025.149466_b0130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nature Reviews Gastroenterology & Hepatology."},{"issue":"24","key":"10.1016\/j.gene.2025.149466_b1225","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1002\/1873-3468.14453","article-title":"HNF4\u03b1 overexpression enhances the therapeutic potential of umbilical cord mesenchymal stem\/stromal cells in mice with acute liver failure","volume":"596","author":"Yu","year":"2022","journal-title":"FEBS Letters."},{"issue":"1","key":"10.1016\/j.gene.2025.149466_b0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-019-1165-5","article-title":"Stem cells: past, present, and future","volume":"10","author":"Zakrzewski","year":"2019","journal-title":"Stem Cell Research & Therapy."},{"issue":"1","key":"10.1016\/j.gene.2025.149466_b1095","first-page":"1","article-title":"MicroRNA-27a regulates hepatic lipid metabolism and alleviates NAFLD via repressing FAS and SCD1","volume":"7","author":"Zhang","year":"2017","journal-title":"Scientific Reports."},{"issue":"5","key":"10.1016\/j.gene.2025.149466_b0530","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.jcyt.2018.02.372","article-title":"Mesenchymal stromal cell exosome\u2013enhanced regulatory T-cell production through an antigen-presenting cell\u2013mediated pathway","volume":"20","author":"Zhang","year":"2018","journal-title":"Cytotherapy."},{"issue":"1","key":"10.1016\/j.gene.2025.149466_b1060","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nm.4453","article-title":"The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitis","volume":"24","author":"Zhang","year":"2018","journal-title":"Nature Medicine."},{"key":"10.1016\/j.gene.2025.149466_b0580","article-title":"The Application of Induced Pluripotent Stem Cells Against Liver Diseases: An Update and a Review","volume":"986","author":"Zhang","year":"2021","journal-title":"Frontiers in Medicine."},{"issue":"2","key":"10.1016\/j.gene.2025.149466_b0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmr.2024.100018","article-title":"Pharmacological treatment for metabolic dysfunction\u2013associated steatotic liver disease and related disorders: Current and emerging therapeutic options","volume":"77","author":"Zhang","year":"2025","journal-title":"Pharmacological Reviews."},{"issue":"8","key":"10.1016\/j.gene.2025.149466_b0630","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.jcyt.2016.04.009","article-title":"Human amniotic epithelial cells attenuate TGF-\u03b21-induced human dermal fibroblast transformation to myofibroblasts via TGF-\u03b21\/Smad3 pathway","volume":"18","author":"Zhao","year":"2016","journal-title":"Cytotherapy."},{"issue":"5","key":"10.1016\/j.gene.2025.149466_b0440","doi-asserted-by":"crossref","first-page":"442","DOI":"10.2174\/1574888X14666190308123714","article-title":"Effects of extracellular vesicles derived from mesenchymal stem\/stromal cells on liver diseases","volume":"14","author":"Zheng","year":"2019","journal-title":"Current Stem Cell Research & Therapy."},{"issue":"1","key":"10.1016\/j.gene.2025.149466_b0900","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ymthe.2016.10.019","article-title":"Clinical proof of concept for a novel hepatocyte-targeting GalNAc-siRNA conjugate","volume":"25","author":"Zimmermann","year":"2017","journal-title":"Molecular Therapy."},{"issue":"12","key":"10.1016\/j.gene.2025.149466_b0420","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.1091\/mbc.e02-02-0105","article-title":"Human adipose tissue is a source of multipotent stem cells","volume":"13","author":"Zuk","year":"2002","journal-title":"Molecular Biology of the Cell."}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111925002549?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111925002549?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T13:07:29Z","timestamp":1744895249000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111925002549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":257,"alternative-id":["S0378111925002549"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2025.149466","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cell and gene therapeutic approaches in non-alcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2025.149466","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"149466"}}